Memorial Sloan Kettering Cancer Center
also referred to as: memorial sloan kettering
16 statements across 2 episodes · 9 bullish · 1 bearish · 1 people on the record · first statement Oct 9, 2017 by Jason Klein · said 28 times in 6 episodes since 2017 · across every show →
Mentions by year
brought up most by Ted Seides (15), Jason Klein (12), Bill Ford (1)
tap a year for its mentions
2021 4 mentions in 2 episodes 2 per episode
2019 1 mention in 1 episode
2018 2 mentions in 2 episodes 1 per episode
2017 21 mentions in 1 episode
Everything said about Memorial Sloan Kettering Cancer Center, oldest first
Oct 9, 2017 positive
MSK Investment Team Starts Weekly Meetings with Scientific 'Memorial Moments'
“So every Monday morning, our team gets together, organizational meeting, full team, and we'll begin with what we call Memorial Moments. There, what we're doing is we're either sharing some sort of research that's going on at the organization, some sort of ad t…”
Oct 9, 2017 positive
Oct 9, 2017 positive
Klein: Deep specialized niche research creates substantial institutional investment edge
“The investment world is is a is a series of smaller worlds that are quirky, that are funky, that are differently understood, that are driven by some set of underlying fundamentals in the longer term, but many sets of technicals in the near time. Taking the tim…”
Oct 9, 2017 neutral
Klein Outlines Memorial Sloan Kettering's Target Portfolio Asset Allocation
“The pie looks like using the conventional asset allocation framework that we have, Global equities, roughly 30%. Hedged equities and uncorrelated strategies, roughly 30%. Private equity strategies, all in, roughly 20%. Real asset-based strategies, roughly 10%.…”
Oct 9, 2017
Klein: MSK Divides Managers Evenly Across Three Flexibility Tiers
“Probably a third of the managers have a very meaningful degree of genuine flexibility across many different asset classes. I'd say another third of the managers Have meaningful flexibility within their asset classes. So for example, global equity is a global e…”
Oct 9, 2017 positive
Klein: MSK backs flexible managers who trade across asset classes nimbly
“Really what we're interested in is nimbleness of capital. What we're interested in is managers that can make those real time or more real time trade-offs across asset classes and in a much more nimble format than we're ever going to be able to do.”
Oct 9, 2017 positive
Klein: MSK Freely Shares Ideas Because Cancer Centers Do Not Compete
“One of the big benefits about investing on behalf of the cancer center is we're not in competition with anybody. We're here to help patients. Happy to be collaborative. In a trusted sense, never break a confidence, but happy to be collaborative with people and…”
Oct 9, 2017 positive
Klein: Manager track records must link back to ex-ante research engines
“Ideally, you'd have a manager that has been doing
The same strategy for a long period of time.
So we should be able to see our way mapping a manager's research engine to the returns that they actually have produced.
And then if you have that benefit of the tra…”
Oct 9, 2017 neutral
Klein: True institutional risk is loss sensitivity and liquidity, not volatility
“And by risk there, I don't really mean standard deviation or volatility, but I mean, what's the sensitivity to loss? What's the sensitivity to accessing their capital? How does their capital figure into their plans and their aspirations? And understanding How …”
Oct 9, 2017 positive
Klein: Internally competitive managers make better partners and collaborators
“I would say an internal competitiveness or competitiveness that is internally oriented. Like to find people that are driven, but driven to compete mostly with themselves to do as best as they can. As a result, hopefully that will propel them if they're skilled…”
Oct 9, 2017 negative
Klein: Debating 1-2% positions with elite investment committees is inefficient
“If we're pulling together that kind of a group, and we're discussing a one or two percent position, it's just not the best, highest impact that we can bring their experience to bear on behalf of Memorial Sloan Kettering.”
Oct 9, 2017 positive
Klein: Flexible mandate managers are ideal partners for perpetual investment
“Flexible mandate managers, which is sort of the ideal for us. If we spend the time to research, find the people, understand their worldview, understand their philosophy, understand their risk taking, if we are aligning ourselves with them, Then we can hopefull…”
Oct 9, 2017
Klein: MSK maintains a fully invested portfolio with minimal turnover
“Again, coming back to the turnover question in practice, the answer is, is that we're not turning over the portfolio all that frequently at all. So we have the benefit of being, of having a fully invested portfolio without a whole lot of turnover.”
Oct 9, 2017
Klein: MSK tests manager allocations using a '30 questions' diligence framework
“One of the earlier stages of the gestation period, as it were, something that we call 30 questions. We've got a group of 30 questions that we've put together. Again, it's meant to be informative. It's not meant to be prescriptive, but we're looking at, do we u…”
Dec 16, 2021